The April/May issue of IP Law & Business featured a story about Robert Shafer, a Stanford University researcher whose free HIV database had become embroiled in a patent dispute that led Shafer to believe medical method patents are out of control.
Since that story’s publication, groups representing most of the American medical establishment have become involved in two major patent cases that turn on the same question that Shafer confronted: just what kinds of “technology” should be eligible for patent protection?
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
